Outbreaks of iatrogenic Botulism in Europe: Combating Off-Label Medical Use of Botulinum Neurotoxin (BoNT) in Bariatric Procedures

Nityanand Jain (Coresponding Author), Edouard Lansiaux, Umut Yucel, Swantje Hunermund, Stella Goeschl, Patricia Schlagenhauf (Editor-in-chief)

Research output: Contribution to journalEditorial

1 Citation (Scopus)

Abstract

In late March 2023, the World Health Organization (WHO) issued a disease outbreak notification regarding an iatrogenic outbreak of botulism in 87 patients who underwent bariatric (weight-loss) procedures at two Turkish hospitals. In this editorial, we look at the current outbreak situation, the availability of Botulism Neurotoxin (BoNT) in Turkiye, patient identification, and management. We further discuss the state of current evidence on the effectiveness of BoNT injections for weight loss and the public health response due to the current outbreaks.
Original languageEnglish
Article number101152
Pages (from-to)1-4
Number of pages4
JournalNew Microbes and New Infections
Volume53
DOIs
Publication statusPublished - Jun 2023

Keywords*

  • botulism
  • Europe
  • off-label
  • bariatric
  • weight loss

Field of Science*

  • 3.3 Health sciences
  • 3.2 Clinical medicine

Publication Type*

  • 1.1. Scientific article indexed in Web of Science and/or Scopus database

Fingerprint

Dive into the research topics of 'Outbreaks of iatrogenic Botulism in Europe: Combating Off-Label Medical Use of Botulinum Neurotoxin (BoNT) in Bariatric Procedures'. Together they form a unique fingerprint.

Cite this